Insider · CIK 0001875891
Mir Hashim
Files at RANI (Rani Therapeutics Holdings, Inc.). First filing -, latest -.
Mir Hashim files SEC Form 4 as officer at RANI (Rani Therapeutics Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mir Hashim has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2025 | RANI Rani Therapeutics Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +325,000 | $0.00 | $0 | 325,000 | May 23, 2025 |
Questions about Mir Hashim
Answered from the filings on this page, as of the latest one.
Is Mir Hashim buying or selling?
Mir Hashim has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mir Hashim's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mir Hashim has 0.
Where does Mir Hashim file Form 4?
Mir Hashim has filed Form 4 at RANI (Rani Therapeutics Holdings, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.